{"title": null, "author": null, "url": null, "hostname": null, "description": null, "sitename": null, "date": "2012-11-01", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "Adyuvantes inmunol\u00f3gicos. Determinantes en el balance eficacia-toxicidad de las vacunas contempor\u00e1neas / Immunological adjuvants. Determinant factors in the efficacy-toxicity ratio of the contemporary vaccines\n[Enferm. infecc. microbiol. cl\u00edn. (Ed. impr.)](http://portal.revistas.bvs.br/transf.php?xsl=xsl/titles.xsl&xml=http://catserver.bireme.br/cgi-bin/wxis1660.exe/?IsisScript=../cgi-bin/catrevistas/catrevistas.xis|database_name=TITLES|list_type=title|cat_name=ALL|from=1|count=50&lang=pt&comefrom=home&home=false&task=show_magazines&request_made_adv_search=false&lang=pt&show_adv_search=false&help_file=/help_pt.htm&connector=ET&search_exp=Enferm. infecc. microbiol. cl\u00edn. (Ed. impr.)); 32(2): 106-114, feb. 2014. ilus, tab\nArtigo em Espanhol | IBECS | ID: ibc-118401\nBiblioteca respons\u00e1vel:\n[ES1.1](http://centros.bvsalud.org/?search=ES1.1&prefix=search&lang=pt)\nLocaliza\u00e7\u00e3o: BNCS\nRESUMENPara lograr\n[vacunas]eficaces y seguras para la [prevenci\u00f3n de enfermedades]infecciosas a\u00fan no controladas o re-emergentes, uno de los aspectos de mayor importancia es contar con adyuvantes que permitan inducir una respuesta protectora efectiva con un adecuado perfil de [seguridad]. El [hidr\u00f3xido de aluminio]se ha utilizado como adyuvante en [vacunas]humanas desde 1926, y solo en los \u00faltimos 10 a\u00f1os se han registrado algunos nuevos [productos], a [pesar]de la enorme cantidad de candidatos propuestos, siendo la [toxicidad]el principal factor que ha limitado su introducci\u00f3n en la cl\u00ednica. En este [trabajo]se actualizan los \u00faltimos avances en cuanto a mecanismos de acci\u00f3n y [toxicidad]de los adyuvantes vacunales y se revisan los adyuvantes que han obtenido [licencias]sanitarias y otros que est\u00e1n pr\u00f3ximos a lograrlo\nABSTRACTTo achieve effective and safe\n[vaccines]for the prevention of not yet controlled or re-emergent [infectious diseases], one of the more importance aspects is to have [immunological adjuvants]that allow inducing a protective [immune response]with an appropriate [safety]pro\ufb01le. Since 1926 the aluminium compounds have been used as adjuvants for [human] [vaccines], and only in the last 10 years some new products have been registered. Although there an enormous quantity of proposed candidates, the [toxicity]is the mainfactor that has limited their introduction into the clinic. In this [work]the mechanism of action are updated, and the [toxicity]of the [immunological adjuvants]are revised, especially those that have obtained clinical approval or are close to getting it\nTexto completo: Dispon\u00edvel Cole\u00e7\u00f5es: Bases de dados nacionais / Espanha Contexto em Sa\u00fade: Agenda de Sa\u00fade Sustent\u00e1vel para as Am\u00e9ricas / ODS3 - Sa\u00fade e Bem-Estar Problema de sa\u00fade: Objetivo 10: Doen\u00e7as transmiss\u00edveis / Meta 3.3: Acabar com as doen\u00e7as tropicais negligenciadas e combater as doen\u00e7as transmiss\u00edveis Base de dados: IBECS Assunto principal: Vacinas / Adjuvantes Imunol\u00f3gicos / Controle de Doen\u00e7as Transmiss\u00edveis Aspecto: Determinantes sociais da sa\u00fade Limite: Humanos Idioma: Espanhol Revista: Enferm. infecc. microbiol. cl\u00edn. (Ed. impr.) Ano de publica\u00e7\u00e3o: 2014 Tipo de documento: Artigo Institui\u00e7\u00e3o/Pa\u00eds de afilia\u00e7\u00e3o: Instituto Finlay/Cuba / Universidad de Ciencias M\u00e9dicas de Santiago de Cuba/Cuba", "language": null, "image": null, "pagetype": null, "links": ["#main_container", "#pesquisa", "#footer", "#", "#", "#", "#", "https://politicas.bireme.org/accesibilidad/pt/", "http://bvsalud.org/", "javascript:change_language('pt')", "javascript:change_language('es')", "javascript:change_language('en')", "javascript:change_language('fr')", "https://pesquisa.bvsalud.org/portal/decs-locator/?lang=pt", "https://pesquisa.bvsalud.org/portal/advanced/?lang=pt", "http://bvsalud.org/evideasy/pt", "#", "http://bvsalud.org/", "https://pesquisa.bvsalud.org/portal/?lang=pt", "https://pesquisa.bvsalud.org/portal/?lang=pt&q=au:\"Batista-Duharte, Alexander\"", "https://pesquisa.bvsalud.org/portal/?lang=pt&q=au:\"Lastre, Miriam\"", "https://pesquisa.bvsalud.org/portal/?lang=pt&q=au:\"P\u00e9rez, Oliver\"", "http://portal.revistas.bvs.br/transf.php?xsl=xsl/titles.xsl&xml=http://catserver.bireme.br/cgi-bin/wxis1660.exe/?IsisScript=../cgi-bin/catrevistas/catrevistas.xis|database_name=TITLES|list_type=title|cat_name=ALL|from=1|count=50&lang=pt&comefrom=home&home=false&task=show_magazines&request_made_adv_search=false&lang=pt&show_adv_search=false&help_file=/help_pt.htm&connector=ET&search_exp=Enferm. infecc. microbiol. cl\u00edn. (Ed. impr.)", "http://centros.bvsalud.org/?search=ES1.1&prefix=search&lang=pt", "https://www.facebook.com/sharer.php?u=https://pesquisa.bvsalud.org/portal/resource/pt/ibc-118401", "https://twitter.com/intent/tweet?text=Adyuvantes inmunol\u00f3gicos. Determinantes en el balance eficacia-toxicidad de las vacunas contempor\u00e1neas https://pesquisa.bvsalud.org/portal/resource/pt/ibc-118401", "https://www.linkedin.com/shareArticle?mini=true&url=https://pesquisa.bvsalud.org/portal/resource/pt/ibc-118401&title=Adyuvantes inmunol\u00f3gicos. Determinantes en el balance eficacia-toxicidad de las vacunas contempor\u00e1neas - Portal Regional da BVS", "https://api.whatsapp.com/send?text=Adyuvantes inmunol\u00f3gicos. Determinantes en el balance eficacia-toxicidad de las vacunas contempor\u00e1neas - Portal Regional da BVS - https://pesquisa.bvsalud.org/portal/resource/pt/ibc-118401", "#mark_ab_es", "#mark_ab_en", null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, "https://pesquisa.bvsalud.org/portal/?lang=pt&q=mh:\"Humanos\"", "https://pesquisa.bvsalud.org/portal/?lang=pt&q=mh:\"Vacinas/farmacologia\"", "https://pesquisa.bvsalud.org/portal/?lang=pt&q=mh:\"/epidemiologia\"", "https://pesquisa.bvsalud.org/portal/?lang=pt&q=mh:\"Controle de Doen\u00e7as Transmiss\u00edveis/m\u00e9todos\"", "https://pesquisa.bvsalud.org/portal/?lang=pt&q=mh:\"Adjuvantes Imunol\u00f3gicos/farmacocin\u00e9tica\"", "https://pesquisa.bvsalud.org/portal/?lang=pt&q=mh:\"Doen\u00e7as Transmiss\u00edveis/epidemiologia\"", "https://pesquisa.bvsalud.org/portal/?lang=pt&q=mh:\"Resultado do Tratamento\"", "https://www.elsevier.es/es-revista-enfermedades-infecciosas-microbiologia-clinica-28-articulo-adyuvantes-inmunologicos-determinantes-el-balance-S0213005X1200434X", "javascript:;", "javascript:window.print()", "javascript:export_xml_record('ibc-118401');", "https://www.google.com/search?q=\"Adyuvantes inmunol\u00f3gicos. Determinantes en el balance eficacia-toxicidad de las vacunas contempor\u00e1neas\"", "https://www.elsevier.es/es-revista-enfermedades-infecciosas-microbiologia-clinica-28-articulo-adyuvantes-inmunologicos-determinantes-el-balance-S0213005X1200434X", "javascript:;", "javascript:window.print()", "javascript:export_xml_record('ibc-118401');", "https://www.google.com/search?q=\"Adyuvantes inmunol\u00f3gicos. Determinantes en el balance eficacia-toxicidad de las vacunas contempor\u00e1neas\"", "https://bvsalud.org/contate-nos/", "http://politicas.bireme.org/terminos/pt/", "http://politicas.bireme.org/privacidad/pt/", "javascript:change_output('rss');", "javascript:;", "javascript:print_page();", "javascript:print_page(true);"]}